C-Section breakthrough: scientists track why a key drug fails

NCT ID NCT05488457

First seen Nov 01, 2025 · Last updated May 06, 2026 · Updated 32 times

Summary

This study looks at why the drug oxytocin sometimes fails to stop heavy bleeding after a C-section. Researchers will measure how the drug moves through the body and how well it makes the uterus contract. About 100 women having planned C-sections will take part. The goal is to find better ways to prevent postpartum hemorrhage.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CESAREAN SECTION COMPLICATIONS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Stanford University

    NOT_YET_RECRUITING

    Stanford, California, 94305, United States

    Contact Phone: •••-•••-••••

  • University of Chicago

    RECRUITING

    Chicago, Illinois, 60637, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.